Case-Based Learning on Resolving Diagnostic Ambiguity in Multisystem Clinical Presentations

Abstract

Resolving diagnostic ambiguity in patients presenting with multisystem clinical features remains an enduring challenge in clinical medicine. Case-based learning (CBL) has emerged as a powerful pedagogical tool to enhance clinical reasoning, integrate multidisciplinary knowledge, and improve diagnostic accuracy. This review explores the principles and practical applications of CBL in the context of multisystemic presentations, highlighting current evidence, mechanisms underlying diagnostic uncertainty, and guideline-based approaches for systematic evaluation. Emphasis is placed on the epidemiology of ambiguous presentations, underlying pathophysiological processes, risk stratification, diagnostic algorithms, and the integration of emerging technologies. The article aims to provide clinicians and educators with actionable strategies to improve diagnostic confidence and patient outcomes in complex cases.

Introduction

Multisystem clinical presentations—where symptoms span several organ systems—often pose significant diagnostic dilemmas. The overlap of symptoms between various diseases, atypical manifestations, and the presence of comorbidities can obscure the underlying diagnosis. Traditional didactic teaching methods may not adequately prepare healthcare professionals for such complexity, whereas case-based learning offers a dynamic approach to bridge theoretical knowledge and real-world clinical reasoning. In this article, we review the value of CBL in resolving diagnostic ambiguity, using evidence-based frameworks to enhance the clinical acumen of practitioners.

Epidemiology / Disease Burden

Multisystem disease presentations are commonly encountered in both primary and tertiary care settings. Epidemiological studies indicate that up to 40% of hospital admissions involve cases with ambiguous presentations affecting more than one organ system. The disease burden is particularly high among elderly patients, those with autoimmune disorders, and populations with limited access to specialized care. Misdiagnosis or delayed diagnosis in such contexts contributes to increased morbidity, longer hospital stays, and higher healthcare costs. Data from recent multicenter registries underscore the importance of early and accurate diagnostic strategies, especially in resource-constrained environments.

Pathophysiology

The underlying pathophysiology of multisystem presentations is often multifactorial. Diseases such as systemic lupus erythematosus, vasculitides, and infectious syndromes (e.g., sepsis) can disrupt multiple organ functions via immune-mediated, inflammatory, or metabolic pathways. For example, cytokine storms in systemic inflammatory response syndromes (SIRS) can result in simultaneous pulmonary, renal, and hepatic involvement. Additionally, genetic and environmental factors may modulate disease expression, further complicating clinical assessment. Mechanism-based understanding is essential to distinguish between primary multisystem diseases and secondary involvement due to complications or comorbidities.

Risk Factors

Several risk factors predispose patients to complex, multisystem presentations. These include advanced age, polypharmacy, immunosuppression, underlying chronic illnesses (such as diabetes, chronic kidney disease, or malignancy), and a personal or family history of autoimmune conditions. Social determinants of health, including socioeconomic status and access to care, can also influence the timely recognition and management of ambiguous cases. Recognizing these risk factors facilitates early suspicion, targeted workup, and tailored management strategies.

Clinical Features

Patients with multisystem involvement may present with a constellation of signs and symptoms across diverse organ systems. Common features include fever, fatigue, weight loss, arthralgias, skin rashes, altered mental status, and laboratory findings such as cytopenias or elevated inflammatory markers. The clinical picture may be further complicated by overlapping syndromes, atypical presentations, or masking effects of concurrent treatments. A comprehensive history—incorporating occupational, travel, and family history—alongside a detailed physical examination, is vital for narrowing the differential diagnosis.

Diagnosis

Establishing a diagnosis in multisystem presentations requires a systematic, algorithmic approach. Key steps include: (1) identifying red flag features suggesting life-threatening causes; (2) prioritizing investigations based on organ involvement; (3) integrating laboratory, radiological, and histopathological findings; and (4) utilizing multidisciplinary case conferences when appropriate. The use of diagnostic scoring systems and validated criteria (e.g., ACR/EULAR criteria for autoimmune diseases) improves specificity and sensitivity. Recent advances in biomarker profiling and molecular diagnostics have further refined the diagnostic process, enabling earlier recognition of atypical disease entities.

Treatment & Management

Management strategies are guided by the underlying etiology and the extent of organ involvement. Initial priorities include stabilization of vital functions, treatment of life-threatening complications, and initiation of empiric therapy when indicated. Disease-specific management may involve immunosuppression, antimicrobials, anticoagulation, or supportive care measures. CBL emphasizes the importance of dynamic reassessment and iterative hypothesis testing, as initial diagnoses may evolve with new clinical data. Interdisciplinary collaboration—among internists, specialists, and allied health professionals—is central to optimizing outcomes.

Recent Advances / Emerging Therapies

Emerging diagnostic tools such as next-generation sequencing, advanced imaging modalities (e.g., PET-CT), and machine learning-based clinical decision support systems are transforming the landscape of multisystem disease evaluation. Personalized medicine approaches, including pharmacogenomics and targeted biologic therapies, offer promise for more precise management of complex cases. Additionally, digital platforms for case-based learning enhance continuous professional development, enabling practitioners to stay abreast of evolving evidence and guideline updates.

Guideline Recommendations

Contemporary guidelines from major medical societies (e.g., American College of Physicians, EULAR) advocate for a structured, evidence-based approach to multisystem presentations. Key recommendations include early multidisciplinary involvement, routine use of validated diagnostic criteria, and adherence to organ-specific management protocols. Case-based learning is endorsed as a core pedagogical strategy for medical education, fostering clinical reasoning, teamwork, and reflective practice. Ongoing guideline updates increasingly incorporate novel diagnostic and therapeutic modalities, ensuring alignment with the latest scientific advances.

Conclusion

Resolving diagnostic ambiguity in multisystem clinical presentations demands a blend of sound clinical reasoning, up-to-date knowledge, and collaborative practice. Case-based learning serves as an effective vehicle to synthesize complex information, foster diagnostic acumen, and promote lifelong learning among healthcare professionals. By leveraging emerging diagnostic technologies and adhering to evidence-based guidelines, clinicians can enhance diagnostic accuracy and improve patient outcomes in the face of clinical uncertainty.